|Day Low/High||37.58 / 38.43|
|52 Wk Low/High||27.88 / 44.56|
I've been long Merck for a long time, since way before this pandemic became part of our lives.
The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.
I'm long this name, as I am several of the others involved. Will I add on a day like this?
Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.
These high-quality companies have strong balance sheets and operate in high-demand markets poised to do well through any economic crisis.
Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.
Let's look at the stocks that will get crushed and that you can't touch right now.
I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.
The bullish reversal pattern is appearing not just in single names, but also in whole sectors.
What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.
PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.
There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.
PFE's charts are constructive and traders could go long at current levels.
It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
Welcome to the new era. Social distancing is not without risks, but it is as good as it gets.
After a strong day for fixed-income markets, let's learn from 2008 how to play this volatility.
I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.
When the central bank is on top of their game as they have been of late, credit must go where credit is due.
The daily trading volume has increased over the past two months telling us that PFE is not falling of its own weight but rather investors are voting with their feet.
But don't throw up your arms yet -- here are names that could be golden opportunities.
Here's how we would play shares of the pharmaceutical giant now.
These Dow stocks all yield above 3.3% right now, but are they worth the risk?
This coronavirus remains a China-centric problem? People are not yet dying in other countries. Do we have to worry here? That's the wrong question.
The Medical Technology Stock Letter's top pick rose 357% in 2019.
Also: People's Bank of China, the Fed, U.S./China trade deal, Brexit, USMCA.